Showing results (191-200 of 238) with videos related to
Sort By:
Pageof 24
JAMA Oncology|January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological FeaturesWilliam L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomyHimanshu R Lukka, Stephanie L Pugh, William U Shipley, et al.Cell|June 16, 2023
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCsHongshan Guo, Joanna A Vuille, Ben S Wittner, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnershipJason A Efstathiou, Memory Bvochora-Nsingo, David P Gierga, et al.International Journal of Radiation Oncology, Biology, Physics|February 3, 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, et al.Science Advances|November 22, 2023
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancerYuzhen Zhou, Judit Börcsök, Elio Adib, et al.Clinical Genitourinary Cancer|November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent ChemoradiotherapyBenjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.International Journal of Radiation Oncology, Biology, Physics|July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.European Urology Oncology|March 25, 2020
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific DifferencesJoep J de Jong, Joost L Boormans, Bas W G van Rhijn, et al.International Journal of Radiation Oncology, Biology, Physics|September 4, 2021
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical TrialChristopher U Jones, Stephanie L Pugh, Howard M Sandler, et al.Pageof 24